Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+438.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+438.3%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
156x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 281.93% |
| Q3 2025 | 1.89% |
| Q2 2025 | -11.59% |
| Q1 2025 | 13.80% |
| Q4 2024 | -5.26% |
| Q3 2024 | 10.22% |
| Q2 2024 | -13.74% |
| Q1 2024 | 14.52% |
| Q4 2023 | 16.59% |
| Q3 2023 | 13.95% |
| Q2 2023 | 10.59% |
| Q1 2023 | 14.88% |
| Q4 2022 | 1.81% |
| Q3 2022 | 4.77% |
| Q2 2022 | -6.09% |
| Q1 2022 | 63.17% |
| Q4 2021 | -233.19% |
| Q3 2021 | 20.24% |
| Q2 2021 | 13.18% |
| Q1 2021 | 31.24% |
| Q4 2020 | -886.36% |
| Q3 2020 | -161.09% |
| Q2 2020 | 123.76% |
| Q1 2020 | 3.45% |
| Q4 2019 | -10.35% |
| Q3 2019 | -31.94% |
| Q2 2019 | 30.48% |
| Q1 2019 | -7.65% |
| Q4 2018 | -16.59% |
| Q3 2018 | 16.90% |
| Q2 2018 | -62.94% |
| Q1 2018 | -35.77% |
| Q4 2017 | 1.37% |
| Q3 2017 | 8.23% |
| Q2 2017 | 2.60% |
| Q1 2017 | -17.37% |
| Q4 2016 | -1.62% |
| Q3 2016 | -11.72% |
| Q2 2016 | 7.30% |
| Q1 2016 | -37.93% |